Intervention for Monitoring of Salt Intake in Hypertensive Patients
Community-based Intervention for Monitoring of Salt Intake in Hypertensive Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: PITCHAPORN SONUCH
- Phone Number: 022011000
- Email: pitch_bell@hotmail.com
Study Locations
-
-
-
Bangkok, Thailand, 10400
- Recruiting
- Faculty of Medicine, Ramathibodi Hospital, Mahidol University
-
Contact:
- PITCHAPORN SONUCH
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults 18-70 years of age with hypertension
- Systolic blood pressure > 130 mmHg
- Provided informed consent to participate in the study
Exclusion Criteria:
- Participants with end stage kidney disease
- History of adjust antihypertensive agents or diuretic within 2 weeks before enrollment
- Pregnant or breastfeeding women
- Adjustment of any antihypertensive agents during study period
- Participants with salt supplement
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Investigator
Education, Reformulation, Environmental change, Used salt meter
|
- Education: Education about risk of high sodium intake, type of sodium, nutrition ingredients
- Reformulation: Dietary recommendation in low sodium intake
- Environmental change: Encourage about low sodium intake in community
- Used salt meter: at least 3 times/wk
|
|
Active Comparator: Control
standard treatment with standard education
|
standard treatment
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
24-hour urine sodium excretion
Time Frame: 12 weeks
|
Compare the change of 24-hour urine sodium excretion between intervention group, received education, reformulation, environmental change and monitoring of salt intake by salt meter and control group, received standard treatment
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood pressure
Time Frame: 4, 8 12 weeks
|
Compare the change systolic and diastolic blood pressure between intervention group, received education, reformulation, environmental change and monitoring of salt intake by salt meter and control group, received standard treatment
|
4, 8 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- COA. MURA2021/1004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.